6th Annual Rx & Biotech Portfolio Management
|Event Date/Time: Jan 25, 2005||End Date/Time: Jan 26, 2005|
Portfolio Optimization vs. Prioritization - A Hypothetical Study of the Financial Cost of Strategy in a Diversified Portfolio
Richard M. Bayney, Ph.D., MBA
Vice President, Decision Analysis & Portfolio Management
Johnson & Johnson Pharmaceutical Research & Development
The Portfolio Balancing Act: Integrating Strategy and Financial Valuation
Anthony Artuso, Ph.D.
Senior Director, Strategic Planning and Decision Analysis
Investment in Biopharmaceutical Manufacturing Capacity: When to Decide?
William D. Matthews, Ph.D.
Vice President, R&D Management Operations